Radboud universitair medisch centrum Stichting

Oncology and Molecular Imaging

Radboud universitair medisch centrum Stichting supports research in a broad range of cancer types, including prostate cancer, breast cancer, ovarian cancer, glioblastoma, non-small cell lung cancer, rectal cancer, and renal cell carcinoma. Its portfolio also includes hematologic malignancies such as chronic myeloid leukaemia, myelodysplastic syndromes, and acute myeloid leukemia.

  • Prostate cancer and castration-resistant prostate cancer
  • Thoracic, gastrointestinal, and urologic malignancies
  • Hematologic cancer and cellular immunotherapy
  • PET/CT imaging and tumor-targeted diagnostics

The sponsor’s oncology research also extends to precision imaging and immune-based treatment strategies in both solid tumors and blood cancers.

Cardiovascular and Vascular Disease

The sponsor is actively involved in studies of cardiovascular disease, with emphasis on coronary vasospasm, coronary microvascular dysfunction, angina, heart failure, hypertension, peripheral arterial disease, acute myocardial infarction, and aortic valve stenosis.

  • Coronary vasomotor disorders
  • Aortic valve disease and aortic valve calcification
  • Stroke, intracerebral haemorrhage, and subarachnoid hemorrhage
  • Antithrombotic therapy and vascular protection

Research in this area also includes blood pressure management, vascular imaging, and treatment approaches for ischemic and hemorrhagic cerebrovascular disease.

Infectious Diseases, Immunology, and Inflammation

Clinical studies cover fungal infection, candidemia, tuberculosis, nontuberculous mycobacterial disease, pertussis, sepsis, and HIV infection, alongside immune-mediated conditions such as systemic sclerosis, Sjögren’s syndrome, primary membranous nephropathy, and inflammatory bowel disease.

  • Antifungal and antimicrobial treatment research
  • Host immune response and inflammation
  • Vaccine immunogenicity and infection prevention
  • Autoimmune and immune-mediated renal disease

The sponsor also investigates experimental endotoxemia, immunomodulation, and inflammatory mechanisms linked to acute and chronic disease.

Neurology, Psychiatry, and Pain

Its research portfolio includes Parkinson’s disease, chronic cluster headache, dystonic tremor syndrome, delirium, major depressive disorder, posttraumatic stress disorder, anxiety, fatigue, and GHB use disorder.

  • Movement disorders and tremor syndromes
  • Mood disorders and trauma-related conditions
  • Substance use disorder and detoxification
  • Neurological injury and cognitive complications

Additional work addresses stroke recovery, intracerebral bleeding, and symptom control in chronic pain and neurological disease.

Metabolic, Renal, Gastrointestinal, and Endocrine Disorders

The sponsor funds studies in type 1 diabetes, gestational diabetes, diabetic foot ulcer, chronic pancreatitis, predicted severe acute pancreatitis, primary aldosteronism, hypomagnesemia, and primary membranous nephropathy.

  • Diabetes-related complications
  • Pancreatic inflammation and gastrointestinal disease
  • Kidney disease and electrolyte disorders
  • Hormonal and metabolic regulation

Research also includes nutrition-related interventions, organ failure prevention, and disease management in complex multisystem conditions.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A study to evaluate the effect of obinutuzumab on removing specific immune cells in the tissues of patients with Sjögren’s syndrome.

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of Fast Awakening from General Anesthesia Using a Drug Combination Including Remimazolam in Healthy Volunteers

    Not yet recruiting

    3 1 1 1
    The Netherlands
  • Study of inhaled liposomal amphotericin B and technetium-99m to assess lung distribution in patients with chronic pulmonary aspergillosis

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Imaging Beta Cells in Patients with a History of Gestational Diabetes Using Exenatide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Using Iron Oxide to Visualize Tumor Spread in Glioblastoma Patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands